zidovudine

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instanceOf antiretroviral therapy
protease inhibitor
gptkbp:administeredBy oral
intravenous
gptkbp:alsoKnownAs gptkb:AZT
gptkb:Retrovir
gptkbp:approvalYear 1987
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode J05AF01
gptkbp:bioavailability 60–70% (oral)
gptkbp:CASNumber 30516-87-1
gptkbp:category antiviral drug
World Health Organization essential medicine
gptkbp:chemicalFormula C10H13N5O4
gptkbp:combinationTherapy often combined with lamivudine
gptkbp:contraindication hypersensitivity to zidovudine
gptkbp:developedBy gptkb:Burroughs_Wellcome
gptkbp:discoveredBy gptkb:Jerome_Horwitz
gptkbp:drugClass antiviral
gptkbp:eliminationHalfLife 1 hour
gptkbp:excretion urine
gptkbp:firstSynthesized 1964
https://www.w3.org/2000/01/rdf-schema#label zidovudine
gptkbp:KEGGID gptkb:D00351
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits reverse transcriptase
gptkbp:meltingPoint 125–127 °C
gptkbp:metabolism liver
gptkbp:molecularWeight 267.24 g/mol
gptkbp:pregnancyCategory C (US)
used to prevent HIV transmission to fetus
gptkbp:proteinBinding 34–38%
gptkbp:PubChem_CID gptkb:CHEMBL458
32598
35370
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect gptkb:anemia
nausea
headache
neutropenia
muscular dystrophy
gptkbp:solubility water soluble
gptkbp:UNII 4B9XT59T7S
gptkbp:usedFor HIV infection
prevention of mother-to-child transmission of HIV
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:NRTIs
gptkbp:bfsLayer 5